Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer

Acta Biomed Ateneo Parmense. 1993;64(5-6):171-84.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm / analysis*
  • Biomarkers, Tumor*
  • Carcinoembryonic Antigen / blood*
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Small Cell / diagnosis
  • Carcinoma, Squamous Cell / diagnosis
  • Female
  • Humans
  • Lung Neoplasms / diagnosis*
  • Male
  • Middle Aged
  • Peptides / blood*
  • Phosphopyruvate Hydratase / blood*
  • Radioimmunoassay
  • Sensitivity and Specificity
  • Tissue Polypeptide Antigen

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Peptides
  • Tissue Polypeptide Antigen
  • Phosphopyruvate Hydratase